NHP2 downregulation counteracts h TR ‐mediated activation of the DNA damage response at ALT telomeres

• DOI: 10.15252/embj.2020106336
• Publication Date: 2021-02-20T11:12:19Z
• Authors: Maya Raghunandan; Dan Geelen; Eva Majerova; Anabelle Decottig...
• Keywords: 0303 health sciences; DNA Repair; Heterogeneous Nuclear Ribonucleoprotein A1; Down-Regulation; Nuclear Proteins; Telomere Homeostasis; DNA-Activated Protein Kinase; Telomere; Ribonucleoproteins, Small Nuclear; 03 medical and health sciences; Neoplasms; Humans; RNA; Rad51 Recombinase; Telomerase; DNA Damage

About 10% of cancer cells employ the "alternative lengthening of telomeres" (ALT) pathway instead of re-activating the hTERT subunit of human telomerase. The hTR RNA subunit is also abnormally silenced in some ALT+ cells not expressing hTERT, suggesting a possible negative non-canonical impact of hTR on ALT. Indeed, we show that ectopically expressed hTR reduces phosphorylation of ssDNA-binding protein RPA (p-RPAS33 ) at ALT telomeres by promoting the hnRNPA1- and DNA-PK-dependent depletion of RPA. The resulting defective ATR checkpoint signaling at telomeres impairs recruitment of the homologous recombination protein, RAD51. This induces ALT telomere fragility, increases POLD3-dependent C-circle production, and promotes the recruitment of the DNA damage marker 53BP1. In ALT+ cells that naturally retain hTR expression, NHP2 H/ACA ribonucleoprotein levels are downregulated, likely in order to restrain DNA damage response (DDR) activation at telomeres through reduced 53BP1 recruitment. This unexpected role of NHP2 is independent from hTR's non-canonical function in modulating telomeric p-RPAS33 . Collectively, our study shines new light on the interference between telomerase- and ALT-dependent pathways and unravels a crucial role for hTR and NHP2 in DDR regulation at ALT telomeres.